A first-in-class nanoparticle injection sneaks antibodies into pancreatic cancer cells to clear mutant KRAS, shrinking tumors in mice while sparing healthy tissue.

Insurance coverage of wearables is spotty. This could soon change as Medicare begins a pilot to facilitate access to wearables while gathering data on health outcomes.

though MAHA’s food agenda still features prominently, in practice achieving its goals is being made increasingly difficult by a number of Trump administration policies.

Another brand of baby formula for infants has been recalled by the CDC due to links with botulism cases in babies.

Millions of Americans are currently injecting unapproved chemicals like peptides promoted by hodgepodge of wellness influencers and celebrity podcasters.

By mandating hydration breaks at this year’s World Cup, FIFA is facilitating a change with huge financial implications as airing more ads boosts broadcasting revenue.

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, offering a more precise first‑line.

The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.

Forecasts remain central to healthcare policy evaluation. And so, their accuracy is particularly important in relation to possible expansion of GLP-1 coverage.

Engineered fluorescent nanobodies that work inside living cells can label multiple proteins in different colors at once, revealing real-time cellular activity.